These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 10502441

  • 1. Cervical adenocarcinoma, a novel combination chemotherapy with mitomycin C, etoposide, and cisplatin for advanced or recurrent disease.
    Umesaki N, Izumi R, Fushiki H, Hasegawa K, Kono I, Nishida M, Noguchi H, Okuda H, Sugimori H, Takizawa K, Udagawa Y, Yamamoto K, Tanaka T, Noda K.
    Gynecol Oncol; 1999 Oct; 75(1):142-4. PubMed ID: 10502441
    [Abstract] [Full Text] [Related]

  • 2. Neoadjuvant chemotherapy with mitomycin C, etoposide, and cisplatin for adenocarcinoma of the cervix.
    Iwasaka T, Fukuda K, Hara K, Yokoyama M, Nakao Y, Uchiyama M, Sugimori H.
    Gynecol Oncol; 1998 Aug; 70(2):236-40. PubMed ID: 9740697
    [Abstract] [Full Text] [Related]

  • 3. Cis-platinum, doxorubicin, and methotrexate treatment for recurrent cervical cancer.
    Wheelock JB, Krebs HB, Goplerud DR, Myers M.
    Obstet Gynecol; 1985 Sep; 66(3):410-2. PubMed ID: 4040622
    [Abstract] [Full Text] [Related]

  • 4. Treatment of advanced or recurrent endometrial carcinoma with combination of etoposide, cisplatin, and 5-fluorouracil: a phase II study.
    Pierga JY, Dieras V, Paraiso D, Dorval T, Palangie T, Beuzeboc P, Jouve M, Scholl SM, Garcia-Giralt E, Pouillart P.
    Gynecol Oncol; 1996 Jan; 60(1):59-63. PubMed ID: 8557229
    [Abstract] [Full Text] [Related]

  • 5. Treatment of advanced or recurrent squamous cell carcinoma of the uterine cervix with mitomycin-C, bleomycin, and cisplatin chemotherapy.
    Smith HO, Stringer CA, Kavanagh JJ, Gershenson DM, Edwards CL, Wharton JT.
    Gynecol Oncol; 1993 Jan; 48(1):11-5. PubMed ID: 7678571
    [Abstract] [Full Text] [Related]

  • 6. Phase II trial of doxorubicin, 5-fluorouracil, etoposide, and cisplatin in advanced or recurrent endometrial carcinoma.
    Pierga JY, Diéras V, Beuzeboc P, Dorval T, Palangié T, Jouve M, Scholl SM, Garcia-Giralt E, Pouillart P.
    Gynecol Oncol; 1997 Aug; 66(2):246-9. PubMed ID: 9264570
    [Abstract] [Full Text] [Related]

  • 7. A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer.
    Moore KN, Herzog TJ, Lewin S, Giuntoli RL, Armstrong DK, Rocconi RP, Spannuth WA, Gold MA.
    Gynecol Oncol; 2007 May; 105(2):299-303. PubMed ID: 17303230
    [Abstract] [Full Text] [Related]

  • 8. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
    Zanetta G, Fei F, Mangioni C.
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
    [Abstract] [Full Text] [Related]

  • 9. Chemotherapy of advanced or recurrent cervical carcinoma with a consecutive low-dose cisplatin combined with bleomycin, vincristine, and mitomycin-C (consecutive low-dose BOMP).
    Shimizu Y.
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():359-77. PubMed ID: 10895181
    [Abstract] [Full Text] [Related]

  • 10. [Neoadjuvant chemotherapy before radiotherapy in treatment of patients with cervical carcinoma].
    Li QS, Zhang XQ, Li DP, Sheng XG, Du XL, Song QQ.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):83-7. PubMed ID: 16640853
    [Abstract] [Full Text] [Related]

  • 11. The activity of carboplatin and paclitaxel for recurrent cervical cancer after definitive radiotherapy.
    Mabuchi S, Morishige K, Fujita M, Tsutsui T, Sakata M, Enomoto T, Kimura T.
    Gynecol Oncol; 2009 May; 113(2):200-4. PubMed ID: 19268342
    [Abstract] [Full Text] [Related]

  • 12. Cisplatin/etoposide chemotherapy for recurrent or primarily advanced cervical carcinoma.
    Al-Saleh E, Hoskins PJ, Pike JA, Swenerton KD.
    Gynecol Oncol; 1997 Mar; 64(3):468-72. PubMed ID: 9062152
    [Abstract] [Full Text] [Related]

  • 13. [Chemotherapy of cancers of the uterine cervix with a combination of bleomycin, mitomycin, cisplatin and etoposide].
    Chauvergne J, Héron JF, Mayer F, Charrot-Chinet P, Toulouse C.
    Bull Cancer; 1993 Jan; 80(1):70-9. PubMed ID: 7515729
    [Abstract] [Full Text] [Related]

  • 14. The outcome of advanced or recurrent non-squamous carcinoma of the uterine cervix after platinum-based combination chemotherapy.
    Kastritis E, Bamias A, Efstathiou E, Gika D, Bozas G, Zorzou P, Sarris K, Papadimitriou C, Dimopoulos MA.
    Gynecol Oncol; 2005 Nov; 99(2):376-82. PubMed ID: 16051322
    [Abstract] [Full Text] [Related]

  • 15. Neoadjuvant chemotherapy using low-dose consecutive intraarterial infusions of cisplatin combined with 5-fluorouracil for locally advanced cervical adenocarcinoma.
    Aoki Y, Sato T, Watanabe M, Sasaki M, Tsuneki I, Tanaka K.
    Gynecol Oncol; 2001 Jun; 81(3):496-9. PubMed ID: 11371145
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cis-platinum and mitomycin-C in treatment of recurrent, metastatic, or residual uterine cervical cancer post radiation.
    Senapad S, Neungton S, Usavajindawath C, Vijatrasil S, Thaithanaisawanya V.
    J Med Assoc Thai; 1989 Jul; 72(7):382-6. PubMed ID: 2507723
    [Abstract] [Full Text] [Related]

  • 18. [Evaluation of neoadjuvant chemotherapy for locally advanced cervical cancinoma].
    Cheng XD, Lü WG, Ye F, Chen HZ, Xie X.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):95-8. PubMed ID: 16640856
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [The immediate results of the combined chemotherapy of disseminated forms and recurrences of cervix uteri cancer with vincristine, platidiam and adriamycin].
    Zabunov AV, Dudareva LA.
    Vopr Onkol; 1991 Feb; 37(11-12):1090-4. PubMed ID: 1669203
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.